The Business Research Company’s report on the Continuous Glucose Monitor System Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the key drivers behind the continuous glucose monitor system market’s growth in recent years?
The increasing prevalence of diabetes is expected to propel the growth of the continuous glucose monitor system market going forward. Diabetes is a chronic medical condition characterized by high blood sugar levels resulting from the body’s inability to produce or use insulin effectively. The rise in diabetes is primarily attributed to factors such as increasing rates of obesity, unhealthy diets, physical inactivity, and an aging population. Continuous glucose monitoring (CGM) systems provide real-time glucose readings, helping manage diabetes by detecting trends and alerting users to abnormal levels. They improve glycemic control while minimizing the need for frequent finger pricks. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the increasing prevalence of diabetes is driving the growth of the continuous glucose monitor system market.
Access Your Free Sample of the Global Continuous Glucose Monitor System Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=20732&type=smp
How does the future projection of the continuous glucose monitor system market size compare to its historical growth?
The continuous glucose monitor (CGM) system market size has grown rapidly in recent years. It will grow from $8.83 billion in 2024 to $9.67 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to a growing geriatric population, growing awareness of diabetes management, rising disposable income, increasing investment in research and development, and increasing healthcare expenditure.
The continuous glucose monitor (CGM) system market size is expected to see rapid growth in the next few years. It will grow to $17.00 billion in 2029 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to the increasing prevalence of diabetes, rising cases of obesity, increasing socio-economic changes, increasing clinical trials, and increasing urbanization. Major trends in the forecast period include integration with smart devices, increasing use of artificial intelligence (AI), non-invasive monitoring solutions, wearable technology expansion, the rise of telemedicine, and remote healthcare solutions.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=20732&type=smp
Which key players are shaping the future of the continuous glucose monitor system market?
Major companies operating in the continuous glucose monitor system market are Abbott Corporation, Medtronic PLC, Murata Manufacturing Co. Ltd., Dexcom Inc., Sinocare Inc., Tandem Diabetes Care Inc., Ascensia Diabetes Care Holdings AG, Glooko Inc., DarioHealth Corp., Menarini Diagnostics SRL, Senseonics Holdings Inc., WaveForm Technologies Inc., Medtrum Technologies Inc., Biolinq Incorporated, Ultrahuman Inc., GlySens Incorporated, Glucotrack, EOFLOW CO. LTD., Nemaura Medical Inc., Meiqi Medical Equipment, Nipro Diagnostics UK Limited
What trends will propel the growth and evolution of the continuous glucose monitor system market?
Major companies operating in the continuous glucose monitor system market are focusing on developing advanced over-the-counter continuous glucose monitors (CGMs) to enhance accessibility and expand their reach among non-prescription users. An over-the-counter (OTC) continuous glucose monitor (CGM) is a device that tracks glucose levels in real-time without a prescription. It provides consumers with easy, convenient access to monitor their glucose independently. For instance, in September 2024, Abbott Laboratories, a US-based medical device company, launched Lingo in the United States. Designed for adults without diabetes, Lingo enables users to track glucose levels, offering valuable insights into the effects of diet and exercise on overall health. With a wearability of up to 14 days, this device supports Abbott’s strategy to tap into the growing market of consumers focused on prediabetes management and wellness, all without the need for a prescription.
Which regions are expected to become dominant players in the continuous glucose monitor system market?
North America was the largest region in the continuous glucose monitor (CGM) system market in 2024. The regions covered in the continuous glucose monitor system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
What are the emerging key segments in the continuous glucose monitor system market, and how are they evolving?
The continuous glucose monitor system market covered in this report is segmented –
1) By Component: Transmitters, Receivers, Sensor
2) By Technology: Real Time Continuous Glucose Monitoring, Intermittently Scanned Continuous Glucose Monitoring
3) By Demography: Child Population, Adult Population
4) By Application: Type-1 Diabetes, Type-2 Diabetes, Gestational Diabetes
5) By End-User: Diagnostics Centers, Hospitals, Clinics, Intensive Care Unit (ICUs), Home Healthcare
Subsegments:
1) By Transmitters: Bluetooth-Enabled Transmitters, Wireless Transmitters
2) By Receivers: Dedicated Devices (CGM Receiver), Smartphone-Based Receivers, Cloud-Connected Receivers
3) By Sensor: Enzyme-Based Sensors, Non-Enzyme-Based Sensors, Electrochemical Sensors
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20732
What defines the structure and scope of the continuous glucose monitor system market?
A continuous glucose monitoring (CGM) system is a medical device designed for individuals with diabetes to continuously track their glucose levels in real time. The system usually includes a small sensor inserted under the skin that measures glucose levels in the interstitial fluid, transmitting this data to a receiver or smartphone app for easy monitoring. This technology helps users make informed decisions about insulin dosing and lifestyle choices to manage their blood sugar effectively.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
